Neuroblastoma, a childhood tumor of the developing nervous system, exhibits primary ALK mutations in ∼7% of samples, most commonly in the kinase domain, in both sporadic and familial forms (De Brouwer et al., 2010; Hallberg and Palmer, 2013; Schleiermacher et al., 2014). This evidence concerns the gene ALK and neuroblastoma.